RECENT MEDICAL JOURNAL ARTICLES THAT ARE AVAILABLE AT NO COST

The articles below serve as examples of the wide range of recently published research findings and other scientific information about ocular melanoma. They are frequently from "open-access" journals because those journals provide public access at no cost as soon as their articles are published. However, there will be more opportunities for immediate no-cost access because journal articles related to NIH-funded work are now federally required, as of July 2025, to be available for free without a waiting period.

The journal articles were found through the National Institutes of Health's PubMed database using the pre-set links provided to you on EyeMelanoma.org's "How to Search for Medical Journal Articles" webpage. (Importantly, the "How to Search" webpage also provides detailed information on how to define your own search criteria as well as suggestions on how to potentially find free access to the articles published in fee-based journals. Performing your own customized search is strongly encouraged.)

Two main categories of journal articles — Reviews and Original Research — make up the list below. After each article's title, its category has been noted for you. If interested, you can also view a comparison chart showing "the difference between a systematic review and a literature review" (from USC Medical Library) and a five-minute video on "how to read and comprehend scientific research articles" (from UMN Libraries).

Each of these NO-COST JOURNAL ARTICLE EXAMPLES has been linked to its PDF version for easier readability and printing. This list has separate sections for uveal melanoma and for conjunctival melanoma.

>>  "Retrospective Multicenter Analysis of Real-Life Toxicity and Outcome of Ipilimumab and Nivolumab in Metastatic Uveal Melanoma" (Original Research)

Authors: Ciernik, Ciernik, Bonczkowitz, et al. The Oncologist, July 2025.

>>  "Long-Term Non-Conditional and Conditional Metastasis of Uveal Melanoma by Tumor Size Category in 8034 Patients" (Original Research)

Authors: Bansai, Sener, Shields, et al. Indian Journal of Ophthalmology, May 2025.

>>  "BAP1 Loss Affords Lipotoxicity Resistance in Uveal Melanoma" (Original Research)

Authors: Cunanan, Amirfallah, Sanders, et al. Pigment Cell & Melanoma Research, May 2025.

>>  "Early Treatment in Patients With Small and Medium-Small Class 2 Gene Expression Profiling Uveal Melanoma to Reduce Mortality" (Original Research)

Authors: González, Villegas, Gold, et al. Journal of VitreoRetinal Diseases, April 2025.

>>  "An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma" (Original Research)

Authors: Zager, Marloff, Ferrucci, et al. Annals of Surgical Oncology, April 2025.

>>  "Optimizing TIL [Tumor Infiltrating Lymphocytes] Therapy for Uveal Melanoma: Lessons Learned and Unlearned from Cutaneous Melanoma" (Review)

Authors: Leonard-Murali and Kammula. Immunotherapy, March 2025.

>>  "BAP1 Tumor Predisposition Syndrome" (Review)

Authors: Pilarski, Byrne, Carlo, et al. GeneReviews, December 2024.

>>  "Proton Therapy in Uveal Melanoma" (Review)

Authors: Chan, Lin, Yacoub, et al. Cancers, October 2024.

>>  "Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma" (Review)

Authors: Varela, Villatoro, Lorenzo, et al. Cancers, September 2024.

>>  "Long-Term Survival Follow-Up for Tebentafusp in Previously Treated Metastatic Uveal Melanoma" (Original Research)

Authors: Sacco, Carvajal, Butler, et al. Journal for ImmunoTherapy of Cancer, June 2024. 

>>  "Current and Emerging Radiotherapy Options for Uveal Melanoma" (Review)

Authors: Semeniuk, Yu, and Rivard. Cancers, March 2024.

>>  "From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma" (Review)

Authors: Synoradzki, Paduszyńska, Solnik, et al. Current Oncology, February 2024.

>>  "Surveillance for Metastasis in High-Risk Uveal Melanoma Patients: Standard Versus Enhanced Protocols" (Original Research)

Authors: Yesiltas, Zabor, Wrenn, et al. Cancers, October 2023.

>>  "Emerging Techniques in the Treatment of Conjunctival Melanoma" (Review)

Authors: Li, Venkateswaran, Antonietti, et al. Current Ophthalmology Reports, June 2025.

>>  "Conjunctival Melanoma: A Narrative Review of Current Knowledge" (Review)

Authors: Papaoikonomou, Pavlidis, Apalla, et al. Pigment Cell & Melanoma Research, March 2025.

>>  "Metastatic Conjunctival Melanoma: A Multicentre International Study" (Original Research)

Authors: Jain, Finger, Filì, et al. British Journal of Ophthalmology, December 2024.

>>  "Epigenetics of Conjunctival Melanoma: Current Knowledge and

Future Directions" (Review)

Authors: Flick, Demirci, and Demirci. Cancers, October 2024.

>>  "Conjunctival Melanoma: A Clinical Review and Update" (Review)

Authors: Butt, Hussain, Coupland, et al. Cancers, September 2024.

>>  "Artificial Intelligence and Machine Learning a New Frontier in the Diagnosis of Ocular Adnexal Tumors: A Review" (Review)

Authors: Qurban and Cassidy. Sage Open Medicine, August 2024.

>>  "Pediatric Conjunctival Melanoma: A Comprehensive Case Report and Literature Review" (Case Report and Review)

Authors: Cantu-Soriano, Sanchez, Suarez-Reynoso, et al. American Journal of Ophthalmology Case Reports, May 2024.

>>  "Conjunctival Nevus" (Review)

Authors: Huang, Locatelli, Chocron, et al. Current Ophthalmology Reports, December 2023.

>>  "A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance" (Original Research)

Authors: Mudhar, Krishna, Cross, et al. Laboratory Investigation, November 2023.